Tailwinds' Take: this long-awaited data came out better than anyone could have asked for. Not only demonstrating effectiveness, but improving in efficacy over time is phenomenal. HJLI still needs more capital, but, hopefully, these results will be enough to...
Tailwinds' Take: While this is not unexpected, PRIME designation is still good news for PRVB. We believe that, based on the stock's trading over the last few days, that a low has been put in place for Provention and...
As we head into the home stretch of 2019 the market for microcap stocks seems to have turned around. This time last year it was decimation in my space. Twenty-nineteen was shaping up that way over the last three...
Tailwinds' Take: with the data being released at a conference, one can assume that it will be positive; as all trial data has been to date. This is a big catalyst for sparking strategic interest and HJLI will be...
Tailwinds' Take: the endpoints for this trial, time to recurrence and volume removed, should be easy for a well-known drug like Terlipressin to achieve. Next step for BIVI is obtaining funding. Once funded, this could be one of the...
Tailwinds' Take: This drug is rather meaningless to the PRVB story, which is all about Type 1 Diabetes at this time. I think there's a good chance Janssen repurchases it or they get a similar amount of money from...
Tailwinds' Take: With CLIA approval for Cchek in prostate cancer expected within weeks, Anixa is already moving forward on a second indication. The recent hire of a solid head of the diagnostics' area and the success they are showing...
Tailwinds' Take: this partnership with the market leader in connectivity in the travel industry is a game-changing event for MKGI. We should expect Monaker to gain almost immediate access to many thousands of travel agents and to see volumes jump...
On Monday morning, HyreCar (HYRE) put out a press release discussing the onboarding of two large multi-location dealers to their platform. This is obviously great news as the Company’s success is dependent upon adding new vehicles to the platform;...
TORONTO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (PAT.TO) (PTOTF) (0PL.F) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert Threat Detection Platform, is pleased to announce the sale of its PATSCAN Multi-Sensor Covert Threat Detection...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.